Darin Lippoldt

Companies

• Neurocrine BiosciencesGeneral counsel Nov 4, 2014 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Neurocrine Biosciences NBIX56,793 shares²$7.8M at $136.95Sep 11, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 11, 2026Shares withheld for tax 2,419 shares at $156.22 of Neurocrine Biosciences²
• Sep 11, 2026Granted 4,483 shares of Neurocrine Biosciences²
• Jul 9, 2026Sold 10,000 shares at $179.60 of Neurocrine Biosciences³
• Jul 9, 2026Exercised options 10,000 shares at $81.49 of Neurocrine Biosciences³
• Jun 29, 2026Sold 1,690 shares at $170.81 of Neurocrine Biosciences⁴
• Jun 29, 2026Exercised options 1,690 shares at $81.49 of Neurocrine Biosciences⁴
• Jun 29, 2026Sold 8,110 shares at $170.03 of Neurocrine Biosciences⁴
• Jun 29, 2026Exercised options 8,110 shares at $81.49 of Neurocrine Biosciences⁴
• Jun 26, 2026Sold 200 shares at $169.57 of Neurocrine Biosciences⁴
• Jun 26, 2026Exercised options 200 shares at $81.49 of Neurocrine Biosciences⁴
• Feb 13, 2026Gift 365 shares of Neurocrine Biosciences⁵
• Feb 13, 2026Shares withheld for tax 5,378 shares at $124.12 of Neurocrine Biosciences⁵
• Feb 13, 2026Granted 9,968 shares of Neurocrine Biosciences⁵
• Feb 13, 2026Shares withheld for tax 1,124 shares at $124.12 of Neurocrine Biosciences⁵
• Feb 13, 2026Exercised options 2,083 shares of Neurocrine Biosciences⁵
• Feb 13, 2026Shares withheld for tax 1,089 shares at $124.12 of Neurocrine Biosciences⁵
• Feb 13, 2026Exercised options 2,017 shares of Neurocrine Biosciences⁵
• Feb 12, 2026Shares withheld for tax 967 shares at $123.10 of Neurocrine Biosciences⁵
• Feb 12, 2026Exercised options 1,792 shares of Neurocrine Biosciences⁵
• Jan 31, 2026Shares withheld for tax 1,335 shares at $136.06 of Neurocrine Biosciences⁶
• Jan 31, 2026Exercised options 2,373 shares of Neurocrine Biosciences⁶
• Jan 8, 2026Exercised options 3,349 shares at $35.99 of Neurocrine Biosciences⁷
• Dec 8, 2025Sold 4,376 shares at $159.65 of Neurocrine Biosciences⁸
• Dec 8, 2025Exercised options 4,376 shares at $43.24 of Neurocrine Biosciences⁸
• Feb 13, 2025Sold 1,086 shares at $116.75 of Neurocrine Biosciences⁹